NCT05074719View on ClinicalTrials.gov

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)

CompletedOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
SARS-CoV-2 InfectionCOVID-19Coronavirus InfectionSARS (Severe Acute Respiratory Syndrome)
Trial Locations (1)

98104

University of Washington International Clinical Research Center, Seattle

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Fred Hutchinson Cancer Center

OTHER

lead

University of Washington

OTHER

NCT05074719 - Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) | Biotech Hunter | Biotech Hunter